BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21596106)

  • 1. Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats.
    Okubo K; Takahashi T; Sekiguchi F; Kanaoka D; Matsunami M; Ohkubo T; Yamazaki J; Fukushima N; Yoshida S; Kawabata A
    Neuroscience; 2011 Aug; 188():148-56. PubMed ID: 21596106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
    Takahashi T; Aoki Y; Okubo K; Maeda Y; Sekiguchi F; Mitani K; Nishikawa H; Kawabata A
    Pain; 2010 Jul; 150(1):183-191. PubMed ID: 20546998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the endogenous hydrogen sulfide/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice.
    Matsunami M; Miki T; Nishiura K; Hayashi Y; Okawa Y; Nishikawa H; Sekiguchi F; Kubo L; Ozaki T; Tsujiuchi T; Kawabata A
    Br J Pharmacol; 2012 Oct; 167(4):917-28. PubMed ID: 22646666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.
    Sekiguchi F; Miyamoto Y; Kanaoka D; Ide H; Yoshida S; Ohkubo T; Kawabata A
    Biochem Biophys Res Commun; 2014 Feb; 445(1):225-9. PubMed ID: 24508802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Cav3.2 and TRPA1 channels targeted by hydrogen sulfide in pancreatic nociceptive processing in mice with or without acute pancreatitis.
    Terada Y; Fujimura M; Nishimura S; Tsubota M; Sekiguchi F; Kawabata A
    J Neurosci Res; 2015 Feb; 93(2):361-9. PubMed ID: 25267397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
    Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
    PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals.
    Terada Y; Kawabata A
    Handb Exp Pharmacol; 2015; 230():217-30. PubMed ID: 26162837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide as a novel nociceptive messenger.
    Kawabata A; Ishiki T; Nagasawa K; Yoshida S; Maeda Y; Takahashi T; Sekiguchi F; Wada T; Ichida S; Nishikawa H
    Pain; 2007 Nov; 132(1-2):74-81. PubMed ID: 17346888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
    Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
    Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents.
    Nishimura S; Fukushima O; Ishikura H; Takahashi T; Matsunami M; Tsujiuchi T; Sekiguchi F; Naruse M; Kamanaka Y; Kawabata A
    Gut; 2009 Jun; 58(6):762-70. PubMed ID: 19201768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic hydrogen sulfide-induced visceral pain and referred hyperalgesia involve activation of both Ca(v)3.2 and TRPA1 channels in mice.
    Tsubota-Matsunami M; Noguchi Y; Okawa Y; Sekiguchi F; Kawabata A
    J Pharmacol Sci; 2012; 119(3):293-6. PubMed ID: 22785020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the cystathionine-γ-lyase/Ca
    Tsubota M; Okawa Y; Irie Y; Maeda M; Ozaki T; Sekiguchi F; Ishikura H; Kawabata A
    Neuropharmacology; 2018 May; 133():254-263. PubMed ID: 29407215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical application of disodium isostearyl 2-O-L-ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats.
    Okubo K; Nakanishi H; Matsunami M; Shibayama H; Kawabata A
    Br J Pharmacol; 2012 Jun; 166(3):1058-68. PubMed ID: 22229645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of interleukin-6 on Ca
    Liu Q; Chen W; Fan X; Wang J; Fu S; Cui S; Liao F; Cai J; Wang X; Huang Y; Su L; Zhong L; Yi M; Liu F; Wan Y
    Exp Neurol; 2019 Jul; 317():226-243. PubMed ID: 30872136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide-induced colonic mucosal cytoprotection involves T-type calcium channel-dependent neuronal excitation in rats.
    Matsunami M; Kirishi S; Okui T; Kawabata A
    J Physiol Pharmacol; 2012 Feb; 63(1):61-8. PubMed ID: 22460462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Ca
    Liu QY; Chen W; Cui S; Liao FF; Yi M; Liu FY; Wan Y
    Neurosci Res; 2019 May; 142():30-37. PubMed ID: 29684385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
    Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
    Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel increases high voltage-dependent calcium channel current in dorsal root ganglion neurons of the rat.
    Kawakami K; Chiba T; Katagiri N; Saduka M; Abe K; Utsunomiya I; Hama T; Taguchi K
    J Pharmacol Sci; 2012; 120(3):187-95. PubMed ID: 23090716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
    Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
    J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice.
    Okubo K; Matsumura M; Kawaishi Y; Aoki Y; Matsunami M; Okawa Y; Sekiguchi F; Kawabata A
    Br J Pharmacol; 2012 Jul; 166(5):1738-43. PubMed ID: 22300342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.